Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.
Advancing knowledge in the field of heart failure management
The European Journal of Heart Failure (EJHF) is dedicated to the advancement of knowledge in the field of heart failure management.
The journal publishes reviews and editorials to improve the understanding, prevention, investigation and treatment of heart failure. Molecular and cellular biology, pathology, physiology, electrophysiology, pharmacology, as well as clinical, social and population sciences all form part of the discipline.
Supervised exercise training in patients with advanced heart failure and left ventricular assist device: A multicentre randomized controlled trial (Ex‐VAD trial)
Author(s):
Anna Feuerstein,
Felix Schoenrath,
Evgeny Belyavskiy,
Jan Knierim,
Tim Friede,
Marius Placzek,
Doris Bach,
Elisabeth Pieske‐Kraigher,
Christoph Herrmann‐Lingen,
Ralf Westenfeld,
Michael Roden,
Meike Rybczynski,
Nicolas Verheyen,
Marcus Dörr,
Stephan Haehling,
Stefan Störk,
Martin Halle,
Volkmar Falk,
Burkert Pieske,
Frank Edelmann
26 Sep 2023
Practical algorithms for early diagnosis of heart failure and heart stress using NT‐proBNP: A clinical consensus statement from the Heart Failure Association of the ESC
Author(s):
Antoni Bayes‐Genis,
Kieran F. Docherty,
Mark C. Petrie,
James L. Januzzi,
Christian Mueller,
Lisa Andreson,
Biykem Bozkurt,
Javed Butler,
Ovidiu Chioncel,
John G.F. Cleland,
Ruxandra Christodorescu,
Stefano Del Prato,
Finn Gustafsson,
Carolyn S.P. Lam,
Brenda Moura,
Rodica Pop‐Busui,
Petar Seferovic,
Maurizio Volterrani,
Muthiah Vaduganathan,
Marco Metra,
Giuseppe Rosano
27 Sep 2023
Using combinational diuretics across the spectrum of renal function
Author(s):
Pieter Martens,
Wilfried Mullens
26 Sep 2023
From prediction to prevention: The role of heart failure risk models
Author(s):
Matthew W. Segar,
Neil Keshvani,
Ambarish Pandey
Our mission: To reduce the burden of cardiovascular disease.
Our mission: To reduce the burden of cardiovascular disease.